Berentzen-Gruppe Aktiengesellschaft (FRA:BEZ)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	38	36	55	54	60	52
Market Cap Growth	-35.38%	-35.38%	1.92%	-9.46%	14.44%	-19.01%
Enterprise Value	44	52	68	51	56	50
Last Close Price	4.00	3.73	5.47	5.38	5.67	4.85
PE Ratio	-	-	63.53	25.66	16.26	42.21
PS Ratio	0.21	0.20	0.30	0.31	0.41	0.34
PB Ratio	0.82	0.77	1.16	1.08	1.22	1.10
P/TBV Ratio	1.00	0.94	1.44	1.32	1.51	1.43
P/FCF Ratio	37.89	35.54	-	-	16.48	5.80
P/OCF Ratio	5.28	4.95	-	10.97	5.12	3.82
EV/Sales Ratio	0.24	0.29	0.37	0.29	0.38	0.32
EV/EBITDA Ratio	3.37	4.46	6.09	4.21	4.38	4.38
EV/EBIT Ratio	10.00	11.69	16.04	10.16	10.71	13.78
EV/FCF Ratio	44.52	52.05	-	-	15.37	5.58
Debt / Equity Ratio	0.34	0.34	0.33	0.08	0.22	0.22
Debt / EBITDA Ratio	1.21	1.21	1.24	0.29	0.78	0.82
Debt / FCF Ratio	15.96	15.96	-	-	2.99	1.15
Asset Turnover	1.29	1.29	1.27	1.21	1.02	1.04
Inventory Turnover	2.17	2.17	2.22	2.20	2.08	2.29
Quick Ratio	0.43	0.43	0.41	0.40	0.55	0.60
Current Ratio	1.14	1.14	1.10	1.03	1.03	1.12
Return on Equity (ROE)	-2.67%	-2.67%	1.77%	4.25%	7.62%	2.56%
Return on Assets (ROA)	1.97%	1.97%	1.81%	2.18%	2.26%	1.53%
Return on Capital (ROIC)	4.44%	4.44%	4.52%	5.53%	5.53%	3.88%
Return on Capital Employed (ROCE)	6.80%	6.80%	6.20%	8.40%	8.70%	5.50%
Earnings Yield	-3.31%	-3.53%	1.57%	3.90%	6.15%	2.37%
FCF Yield	2.64%	2.81%	-22.07%	-7.00%	6.07%	17.23%
Dividend Yield	2.74%	2.95%	1.65%	4.09%	3.88%	2.68%
Payout Ratio	-	-	238.96%	98.38%	33.34%	213.30%
Total Shareholder Return	2.74%	2.95%	1.65%	4.09%	3.88%	2.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.